Developer docs
API playgroundTry for free, no card

Search company profiles

Gen9

Full company profile

uuid000duv8

Namestring
Gen9
Legal namestring
Gen9 Genetics
Websiteurl
gen9bio.com
Company typeenum
Private
Founded yearint
2009
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biochemical reagent distribution, life science research supplies, PCR kits and reagents, antibody product catalog, gene synthesis services
Industry2 codes
1Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryYes
2Genotyping Platforms & Services (SNP arrays, GBS, sequencing)
CodeAFABALAEPrimaryNo
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Life Science Research Reagents Distribution
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Product Sales (E-commerce)
TypeOne Time License
Description

Gen9 generates revenue through direct online sales of biochemical reagents, PCR kits, antibodies, cell culture products, and related life science consumables. Products are sold directly to research institutions, laboratories, and biotech companies through their e-commerce platform with pricing ranging from under $100 to over $1,000 per product depending on the reagent type and volume.

gen9bio.com
2Custom Services
TypeOne Time License
Description

The company offers custom services including gene synthesis, custom recombinant antibody production, and other made-to-order biological products that command premium pricing.

gen9bio.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Standard research reagents and consumables
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual unit pricing for antibodies, PCR kits, enzymes, and biological reagents. Prices vary by product type with typical antibody products ranging $300-$600, ExoQuick products $517-$1,504, and standard reagents under $100.

gen9bio.com
2Custom synthesis and production services
ModelOtherBilling cadenceMulti-year contract
Notes

Gene synthesis, custom recombinant antibody production, and other custom services typically require quote-based pricing based on project specifications.

gen9bio.com
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Gen9 Genetics operates the gen9bio.com online storefront distributing a broad catalog of life science research consumables — including PCR kits, antibodies, cytokines, exosome isolation reagents, cloning vectors, cell culture products, and DNA/RNA reagents — sourced from multiple branded suppliers (Bio Basic, GENTAUR, Cygnus Technologies, SBI). Alongside third-party distribution, Gen9 retains proprietary BioFab gene synthesis technology and GeneBytes gene-scale products, plus custom services for gene synthesis and recombinant antibody production.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Gen9 Genetics is a biochemical reagents distributor offering a comprehensive portfolio of laboratory research products. The company provides DNA primer design, cDNA libraries, and qPCR-related products and services. Their main offerings include the Bio Basic product line (biochemicals, buffers, hormones, proteins), Gentaur Antibodies (polyclonal, monoclonal, and secondary antibodies), ExoQuick exosome isolation kits, PCR kits and reagents, Cygnus Technologies ELISA kits, cytokines and growth factors, cloning vectors, cell culture products, and DNA/RNA reagents. The company serves the life science research community through an online catalog platform based in San Jose, California.

Product and service12 records
1Bio Basic Biochemical Product Line
CategoryBiochemical Reagents
Description

Distributed Bio Basic brand biochemical reagents including buffers, hormones, indicators, and proteins for laboratory research applications.

2Gentaur Antibodies Product Line
CategoryAntibodies
Description

Distributed GENTAUR brand antibody portfolio including polyclonal, monoclonal, and secondary antibodies such as rabbit, mouse, goat, and human antibodies for research applications.

3ExoQuick Exosome Isolation Kits
CategoryExosome Isolation Reagents
Description

Distributed SBI Systems Biology Institute ExoQuick exosome isolation kits including ExoQuick-CG, ExoQuick-LP, The Original ExoQuick, and ExoQuick Plasma Prep with Thrombin for extracting exosomes from plasma, serum, and ascites fluid.

4PCR Kits & Reagents Product Line
CategoryPCR Reagents and Kits
Description

Distributed PCR reagent portfolio including cloning kits, DNA extraction kits, DNA cleanup kits, RNA extraction kits, purification kits, and PCR detection reagents for molecular biology workflows.

5Cygnus Technologies ELISA Kits
CategoryELISA Kits
Description

Distributed Cygnus Technologies ELISA kits for detecting host cell proteins and other biomarkers, including bioprocessing applications.

6Cytokines & Growth Factors Product Line
CategoryCytokines and Growth Factors
Description

Distributed cytokines including interleukins, interferons, tumor necrosis factors, angiostatin, B-cell activating factor, beta-defensin, enterokinase, granulocyte stimulating factor, eotaxin, MCP, MIP, and growth factors for cell culture and research applications.

7Cloning Vectors & Plasmids
CategoryCloning Vectors and Plasmids
Description

Distributed cloning vectors and plasmid DNA for molecular biology research and gene cloning applications.

8Cell Culture Products
CategoryCell Culture Reagents
Description

Distributed cell culture products including media, reagents, and cell preparation kits for mammalian and microbial cell work.

9DNA/RNA Reagents
CategoryDNA/RNA Reagents
Description

Distributed DNA/RNA reagents including polymerases, nucleases (endonuclease, exonuclease), ligases, DNA glycosylase, DNA ladder, and extraction chemicals.

10Recombinant Proteins
CategoryRecombinant Proteins
Description

Distributed recombinant proteins including BCA protein, bone morphogenetic proteins, hepatitis B surface antigen, and ubiquitin products for research use.

11Gene Synthesis Services
CategoryCustom Gene Synthesis Services
Description

Custom gene synthesis services offered via Gen9, including the BioFab technology platform and GeneBytes gene-scale synthetic biology product line, for researchers needing custom DNA constructs and pathway building.

12Custom Recombinant Antibody Production
CategoryCustom Antibody Services
Description

Custom recombinant antibody production service supporting antibody engineering applications, offered with quote-based pricing based on project specifications.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Gen9 distributes Bio Basic brand biochemical products including buffers, hormones, indicators, proteins, and biochemical reagents. Bio Basic is listed as one of the primary supplier brands on the Gen9 platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Gen9 distributes GENTAUR brand antibodies including polyclonal, monoclonal, and animal-specific antibodies (mouse, rabbit, goat antibodies). GENTAUR products represent a major product category on the Gen9 platform.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Gen9 distributes Cygnus Technologies products including ELISA kits for bioprocessing applications and detecting host cell proteins.

4SBI (Systems Biology Institute)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Gen9 distributes SBI products including exosome isolation reagents such as the ExoQuick series.

gen9bio.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Gen9 collaborates with iGEM (International Genetically Engineered Machine competition) to apply the BioFab gene synthesis technology platform to the synthetic biology community, providing gene synthesis resources and support for iGEM teams.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Twist Bioscience is a leading DNA synthesis provider serving synthetic biology and genomics researchers with high-throughput gene and oligo synthesis. It directly overlaps with Gen9's BioFab gene synthesis and GeneBytes product positioning.

TypeDirect peer
Description

GenScript offers gene synthesis, recombinant antibody production, and a broad catalog of life science reagents through its online platform. The custom services and reagent distribution model closely mirrors Gen9's combined offering.

TypeDirect peer
Description

IDT is a major supplier of oligonucleotides, PCR/qPCR reagents, and custom DNA/RNA products for research customers. It competes head-on with Gen9's PCR kits, DNA/RNA reagents, and custom synthesis services.

TypeDirect peer
Description

Eurofins Genomics provides gene synthesis, DNA sequencing, and molecular biology reagents globally via an online ordering platform. It overlaps with Gen9's gene synthesis services and broad reagent catalog serving life science researchers.

TypeDirect peer
Description

ATUM offers gene synthesis, protein engineering, and synthetic biology services for researchers. It is comparable to Gen9 as a gene synthesis specialist serving the same synthetic biology community.

TypeBroad incumbent
Description

Bio-Rad is a large life science tools company with extensive PCR/qPCR reagent lines and laboratory instruments. It overlaps with Gen9's PCR kits and reagents category as a much larger incumbent player.

TypeBroad incumbent
Description

Thermo Fisher provides a comprehensive catalog of life science reagents, antibodies, ELISA kits, and PCR products through its e-commerce platforms. It represents the broad incumbent that competes with Gen9 across nearly every product category.

TypeOthers
Description

Agilent is a strategic investor in Gen9 ($21M in 2013) and a major life science tools provider with overlapping reagent and genomics offerings. It is comparable as an investor-distributor relationship and adjacent competitor in molecular biology tools.

TypeEmerging player
Description

Synbio Technologies provides gene synthesis, oligonucleotide synthesis, and synthetic biology services. It is comparable to Gen9's BioFab and GeneBytes offerings as a focused emerging player in gene synthesis.

TypeOthers
Description

Biocompare is an online reagent comparison and procurement platform serving life science researchers. It overlaps with Gen9's e-commerce aggregation role for research biochemicals and biological products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gen9

Life Science Research Reagents Distributiongen9bio.com

Gen9 firmographics

Firmographics
Name
Gen9
Legal name
Gen9 Genetics
Website
https://gen9bio.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Gen9 industry classification

Industry
Product category
Life Science Research Reagents Distribution
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
akta.pro secondary industry
Genotyping Platforms & Services (SNP arrays, GBS, sequencing) (AFABALAE)

Keywords

  • Biochemical reagent distribution
  • Life science research supplies
  • PCR kits and reagents
  • Antibody product catalog
  • Gene synthesis services

Where Gen9 is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Gen9 business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Product Sales (E-commerce): Gen9 generates revenue through direct online sales of biochemical reagents, PCR kits, antibodies, cell culture products, and related life science consumables. Products are sold directly to research institutions, laboratories, and biotech companies through their e-commerce platform with pricing ranging from under $100 to over $1,000 per product depending on the reagent type and volume.
  2. Custom Services: The company offers custom services including gene synthesis, custom recombinant antibody production, and other made-to-order biological products that command premium pricing.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard research reagents and consumables
OtherMulti-year contractCustom synthesis and production services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Gen9 product offering

Product offering

Core offering

Gen9 Genetics operates the gen9bio.com online storefront distributing a broad catalog of life science research consumables — including PCR kits, antibodies, cytokines, exosome isolation reagents, cloning vectors, cell culture products, and DNA/RNA reagents — sourced from multiple branded suppliers (Bio Basic, GENTAUR, Cygnus Technologies, SBI). Alongside third-party distribution, Gen9 retains proprietary BioFab gene synthesis technology and GeneBytes gene-scale products, plus custom services for gene synthesis and recombinant antibody production.

Product overview

Gen9 Genetics is a biochemical reagents distributor offering a comprehensive portfolio of laboratory research products. The company provides DNA primer design, cDNA libraries, and qPCR-related products and services. Their main offerings include the Bio Basic product line (biochemicals, buffers, hormones, proteins), Gentaur Antibodies (polyclonal, monoclonal, and secondary antibodies), ExoQuick exosome isolation kits, PCR kits and reagents, Cygnus Technologies ELISA kits, cytokines and growth factors, cloning vectors, cell culture products, and DNA/RNA reagents. The company serves the life science research community through an online catalog platform based in San Jose, California.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bio Basic Biochemical Product Line Distributed Bio Basic brand biochemical reagents including buffers, hormones, indicators, and proteins for laboratory research applications.
  • Gentaur Antibodies Product Line Distributed GENTAUR brand antibody portfolio including polyclonal, monoclonal, and secondary antibodies such as rabbit, mouse, goat, and human antibodies for research applications.
  • ExoQuick Exosome Isolation Kits Distributed SBI Systems Biology Institute ExoQuick exosome isolation kits including ExoQuick-CG, ExoQuick-LP, The Original ExoQuick, and ExoQuick Plasma Prep with Thrombin for extracting exosomes from plasma, serum, and ascites fluid.
  • PCR Kits & Reagents Product Line Distributed PCR reagent portfolio including cloning kits, DNA extraction kits, DNA cleanup kits, RNA extraction kits, purification kits, and PCR detection reagents for molecular biology workflows.
  • Cygnus Technologies ELISA Kits Distributed Cygnus Technologies ELISA kits for detecting host cell proteins and other biomarkers, including bioprocessing applications.
  • Cytokines & Growth Factors Product Line Distributed cytokines including interleukins, interferons, tumor necrosis factors, angiostatin, B-cell activating factor, beta-defensin, enterokinase, granulocyte stimulating factor, eotaxin, MCP, MIP, and growth factors for cell culture and research applications.
  • Cloning Vectors & Plasmids Distributed cloning vectors and plasmid DNA for molecular biology research and gene cloning applications.
  • Cell Culture Products Distributed cell culture products including media, reagents, and cell preparation kits for mammalian and microbial cell work.
  • DNA/RNA Reagents Distributed DNA/RNA reagents including polymerases, nucleases (endonuclease, exonuclease), ligases, DNA glycosylase, DNA ladder, and extraction chemicals.
  • Recombinant Proteins Distributed recombinant proteins including BCA protein, bone morphogenetic proteins, hepatitis B surface antigen, and ubiquitin products for research use.
  • Gene Synthesis Services Custom gene synthesis services offered via Gen9, including the BioFab technology platform and GeneBytes gene-scale synthetic biology product line, for researchers needing custom DNA constructs and pathway building.
  • Custom Recombinant Antibody Production Custom recombinant antibody production service supporting antibody engineering applications, offered with quote-based pricing based on project specifications.

Companies that use Gen9

Customer profile

Segments3 records

Ideal customer profiles2 records

Gen9 technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Gen9 partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Bio BasiccoreChannel Partner/ Reseller/ DistributorGen9 distributes Bio Basic brand biochemical products including buffers, hormones, indicators, proteins, and biochemical reagents. Bio Basic is listed as one of the primary supplier brands on the Gen9 platform.
  • GENTAURcoreChannel Partner/ Reseller/ DistributorGen9 distributes GENTAUR brand antibodies including polyclonal, monoclonal, and animal-specific antibodies (mouse, rabbit, goat antibodies). GENTAUR products represent a major product category on the Gen9 platform.
  • Cygnus TechnologiesminorChannel Partner/ Reseller/ DistributorGen9 distributes Cygnus Technologies products including ELISA kits for bioprocessing applications and detecting host cell proteins.
  • SBI (Systems Biology Institute)minorChannel Partner/ Reseller/ DistributorGen9 distributes SBI products including exosome isolation reagents such as the ExoQuick series.
  • iGEMcoreStrategic or Co-development PartnerGen9 collaborates with iGEM (International Genetically Engineered Machine competition) to apply the BioFab gene synthesis technology platform to the synthetic biology community, providing gene synthesis resources and support for iGEM teams.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Gen9 competitors and assessment

Company assessment

Direct peers

  • Twist Bioscience: Twist Bioscience is a leading DNA synthesis provider serving synthetic biology and genomics researchers with high-throughput gene and oligo synthesis. It directly overlaps with Gen9's BioFab gene synthesis and GeneBytes product positioning.
  • GenScript: GenScript offers gene synthesis, recombinant antibody production, and a broad catalog of life science reagents through its online platform. The custom services and reagent distribution model closely mirrors Gen9's combined offering.
  • Integrated DNA Technologies (IDT): IDT is a major supplier of oligonucleotides, PCR/qPCR reagents, and custom DNA/RNA products for research customers. It competes head-on with Gen9's PCR kits, DNA/RNA reagents, and custom synthesis services.
  • Eurofins Genomics: Eurofins Genomics provides gene synthesis, DNA sequencing, and molecular biology reagents globally via an online ordering platform. It overlaps with Gen9's gene synthesis services and broad reagent catalog serving life science researchers.
  • ATUM (formerly DNA2.0): ATUM offers gene synthesis, protein engineering, and synthetic biology services for researchers. It is comparable to Gen9 as a gene synthesis specialist serving the same synthetic biology community.

Broad incumbents

  • Bio-Rad Laboratories: Bio-Rad is a large life science tools company with extensive PCR/qPCR reagent lines and laboratory instruments. It overlaps with Gen9's PCR kits and reagents category as a much larger incumbent player.
  • Thermo Fisher Scientific: Thermo Fisher provides a comprehensive catalog of life science reagents, antibodies, ELISA kits, and PCR products through its e-commerce platforms. It represents the broad incumbent that competes with Gen9 across nearly every product category.

Others

  • Agilent Technologies: Agilent is a strategic investor in Gen9 ($21M in 2013) and a major life science tools provider with overlapping reagent and genomics offerings. It is comparable as an investor-distributor relationship and adjacent competitor in molecular biology tools.
  • LabSupply Network / Biocompare: Biocompare is an online reagent comparison and procurement platform serving life science researchers. It overlaps with Gen9's e-commerce aggregation role for research biochemicals and biological products.

Emerging players

  • Synbio Technologies: Synbio Technologies provides gene synthesis, oligonucleotide synthesis, and synthetic biology services. It is comparable to Gen9's BioFab and GeneBytes offerings as a focused emerging player in gene synthesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Gen9 social profiles

Digital presence

Gen9 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gen9 leadership team

Management profile

Number of profiles

Profiles2 records

Gen9 funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gen9 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gen9

What does Gen9 do?

Gen9 Genetics operates the gen9bio.com online storefront distributing a broad catalog of life science research consumables — including PCR kits, antibodies, cytokines, exosome isolation reagents, cloning vectors, cell culture products, and DNA/RNA reagents — sourced from multiple branded suppliers (Bio Basic, GENTAUR, Cygnus Technologies, SBI). Alongside third-party distribution, Gen9 retains proprietary BioFab gene synthesis technology and GeneBytes gene-scale products, plus custom services for gene synthesis and recombinant antibody production.

Is Gen9 a public or private company?

Gen9 is a private company. It is classified as venture growth investor backed and is currently operating.

When was Gen9 founded?

Gen9 was founded in 2009. It employs 11 to 50 people.

Where is Gen9 based?

Gen9 is headquartered in Cambridge, United States, in the North America region.

How does Gen9 make money?

Two revenue lines are on record. Product Sales (E-commerce) is the primary driver. The others are custom Services.

Who are Gen9's main competitors?

Direct peers on record are Twist Bioscience, GenScript, Integrated DNA Technologies (IDT), Eurofins Genomics and ATUM (formerly DNA2.0). Broad incumbents are Bio-Rad Laboratories and Thermo Fisher Scientific. Others are Agilent Technologies and LabSupply Network / Biocompare. Synbio Technologies is listed as an emerging player.

Does Gen9 have an API?

No public API is recorded for Gen9.

What industry is Gen9 in?

Gen9's product category is Life Science Research Reagents Distribution. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of AFABALAE, Genotyping Platforms & Services (SNP arrays, GBS, sequencing). Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGinkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9Ginkgo Bioworks announced the acquisition of Gen9, a pioneer in synthetic DNA synthesis and assembly, on January 20, 2017. The deal brings Gen9's BioFab manufacturing platform, proprietary technologies, and portfolio of more than 125 patents and patents pending related to DNA synthesis into Ginkgo's automated organism engineering foundries. Gen9's technology enables production of long synthetic DNA fragments up to 10,000 base pairs, which will support Ginkgo's pipeline of designing multigene enzyme pathways for cultured ingredients across fragrances, flavors, cosmetics, and nutritional ingredients.TechCrunchBeyond The $1K Genome: DNA ‘Writing’ Comes NextDNA synthesis (genetic "writing") is emerging as the next frontier following the achievement of affordable genome sequencing, with current technologies unable to meet research demand due to high costs and long turnaround times. The article discusses how obtaining 100 to 1,000 genes currently costs $400 per 2000 base pair gene and can take weeks or months from conventional suppliers. Several companies—including Gen9 and Twist Bioscience—are developing alternative approaches using semiconductor platforms and silicon wafer-based synthesis to reduce costs toward a target of $0.02 per base pair.VC News DailyGen9 Closed $21M Strategic InvestmentAgilent Technologies closed a $21 million strategic investment in Gen9, acquiring an equity stake and a seat on the company's board of directors. As part of the partnership, Gen9 will incorporate Agilent's Oligonucleotide Library Synthesis technology into its manufacturing process to enhance high-throughput DNA production capabilities. This funding supports Gen9's expansion of its commercial infrastructure and product development in the synthetic biology sector.VC News DailyGen9 Grabs $1.5MGen9 Inc., a stealth Cambridge, Massachusetts-based company, has received $1.5 million toward a planned $9.6 million funding round, according to SEC filings. The filing documents 13 separate investors in the round, including Scott Schoen, co-president of Thomas H. Lee Partners LP, and George Church, who are listed as related persons. The funding consists of equity and warrant notes for Series B preferred stock.